Project title
新藥-RGN1016首次於人體進行Phase I 臨床試驗
Internal ID
MOST104-2325-B002-042
Principal Investigator
Start Date
November 1, 2015
End Date
October 31, 2016
Investigators
Organizations
Partner Organizations
First in Man Clinical Study of a New Drug-RGN1016
Keywords
RGN1016
學習障礙
阿茲海默症
第一期臨床試驗
藥物動力學
安全性
耐受性
RGN1016
cognitive impairment
Alzheimer5 s disease
Phase I clinical trial
pharmacokinetics
safety
tolerability